Skip to main content

Table 1 Antimicrobial activity of MMPphg on various Gram-negative or Gram-positive bacteria. The significant log reduction units observed (≥ 1 log kill) are marked in bold

From: MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria

Strain

Antibiotic resistance a

Antimicrobial activity (Log10 reduction) b

Escherichia coli

 CMCC(B)44102

No

3.23 ± 0.15 (***)

Staphylococcus aureus

 ATCC6538

No

1.31 ± 0.03 (***)

 KMUST1606BL1486

Yes

1.04 ± 0.11 (***)

Salmonella ser. Enteritidis

 CMCC(B)50335

No

1.08 ± 0.03 (***)

Salmonella ser. Typhi

 CGMCC1.1190

No

0.92 ± 0.01

Salmonella ser. Paratyphi B

 CMCC(B)50094

No

3.42 ± 0.15 (***)

Shigella dysenteriae

 KMUSTDS8

Yes

0.96 ± 0.01

 KMUSTDS6

Yes

1.01 ± 0.01 (***)

Klebsiella pneumoniae

 13A14165

Yes

3.02 ± 0.01 (***)

 13A14918

Yes

1.47 ± 0.03 (***)

 13A15188

Yes

2.49 ± 0.07 (***)

 13A15382

Yes

1.59 ± 0.03 (***)

 1412SP0200

Yes

1.24 ± 0.02 (***)

 1412SP0057

Yes

2.26 ± 0.10 (***)

 13 V1837

Yes

0.97 ± 0.03

 14 V0622

Yes

1.09 ± 0.02 (***)

 1501SP0134

Yes

2.57 ± 0.07 (***)

  1. aDetailed antibiotic-resistant information for the relevant strains is shown in Additional file 4: Table S2; bValues represent mean ± standard deviation. For all tests, the antimicrobial activity was measured after incubating 106 CFU/mL of the bacterial cells with 6 μM MMPphg at 37 °C for 1 h, and six independent replicates were run in each reaction. ***, P < 0.001 for MMPphg-treated cells versus PBS-treated controls